# USTEKINUMAB-TTWE

NDC: 82009-163
Generic name: ustekinumab-ttwe
Labeler / Manufacturer: Quallent Pharmaceuticals Health LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250415

FDA application: BLA761425

## Active ingredients

- USTEKINUMAB: 130 mg/26mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82009-163"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82009-163
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b34392a-ecf6-41bd-8706-d4e9f0b25da8